Open an account

Agilent Technologies

A · NYSE

$173.01+$3.11 (+1.83%)TodayMarket closed ·
Prev close $169.90

About A

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. The company is headquartered in Santa Clara, California and currently employs 18,000 full-time employees. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.

Employees
18,000
Headquarters
Santa Clara, California
Listed
Nov 18, 1999
Sector
Health Care
Industry
Life Sciences Tools & Services
Website
agilent.com

A key statistics

Market cap
47.90B
Price-earnings ratio
33.51
Dividend yield
0.59%
Average volume
2.41M
Volume
1.31M
Open price
$170.94
High today
$174.80
Low today
$170.38
52 Week high
$177.47
52 Week low
$108.35

Agilent Technologies (A) at a glance

Agilent Technologies (A) last traded at $173.01, with a market cap of 47.90B, a price-to-earnings ratio of 33.51 and a dividend yield of 0.59%.

Today the stock has traded between $170.38 and $174.80. The current price is 1.5% above the day's low and 1.0% below its high.

Volume so far is 1.31M shares, below the average of 2.41M shares a day.

Over the past year Agilent Technologies has ranged from $108.35 to $177.47, and now sits 94% of the way up that range.

Agilent Technologies met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $1.62 per share against an estimate of $1.52.

The average analyst price target is $178.09, 2.9% above the current price, from 19 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

84%of 19 analyst ratings say Buy
  • Buy84.2%
  • Hold15.8%
  • Sell0.0%
Price target · 23 analystsAvg $178.09
Low
$156.55
Now
$173.01
High
$199.50

A earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 6 of the last 8 quarters, by 3.0% on average.

  1. Q3 FY24: reported $1.32 per share against an estimate of $1.28
  2. Q4 FY24: reported $1.46 per share against an estimate of $1.44
  3. Q1 FY25: reported $1.31 per share against an estimate of $1.30
  4. Q2 FY25: reported $1.31 per share against an estimate of $1.29
  5. Q3 FY25: reported $1.37 per share against an estimate of $1.39
  6. Q4 FY25: reported $1.59 per share against an estimate of $1.62
  7. Q1 FY26: reported $1.49 per share against an estimate of $1.44
  8. Q2 FY26: reported $1.62 per share against an estimate of $1.52

A news

  • Vandana Singh

    Why Agilent Is Spending up to $270 Million on an AI Pathology Specialist

  • Press releaseBusiness Wire

    Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence

  • Press releaseBusiness Wire

    Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows

  • Press releaseBusiness Wire

    Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers

  • Press releaseBusiness Wire

    Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control

  • Press releaseBusiness Wire

    Agilent Announces Cash Dividend of 25.5 Cents per Share

  • Press releaseBusiness Wire

    CORRECTING and REPLACING Agilent Announces Cash Dividend of 25.5 Cents per Share

  • Press releaseBusiness Wire

    Agilent to Participate in J.P. Morgan U.S. All Stars Conference

Similar companies

Companies in the same industry as Agilent Technologies

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.